Together, they highlight key lessons: PJP can occur across a wide range of CD4 counts, IRIS should be considered after ART initiation, microbiological confirmation remains essential, and comprehensive management requires addressing co-pathogens, nutrition, and adherence, alongside standard antimicrobial therapy. Here, CD4 is linked to pneumocystosis.